Plain-English translation of NCT03918421 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is collecting detailed medical information from patients with a rare nerve condition called IgM-anti-MAG neuropathy. The goal is to gather standardized clinical data that will help doctors better understand how this disease develops, how different patients experience it, and how well current treatments work. Eventually, this information will be used to create a better tool for measuring disability and tracking progress in patients with this condition.
Right now, there is no international agreement on how doctors should assess and treat patients with this rare nerve condition. By collecting detailed, consistent information from many patients in different countries, researchers hope to develop a standardized way to measure how the disease affects patients and to improve how doctors evaluate treatment responses.
You likely qualify if…
You likely don't qualify if…
As a participant, you would share your detailed medical history and allow researchers to collect standardized information about your symptoms, physical function, and antibody levels. This is an observational study, meaning doctors are not testing a new medication—they are simply gathering information about your condition as it naturally progresses. You would likely have appointments at the Lyon hospital where clinical assessments would be performed and your medical records reviewed.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
France